Created in 2007 (Switzerland), PAVIKINE own
402 sister brands
and 17478 competing brands.
PAVIKINE is owned by Merck & Co, listed on the stock exchange of New York
PAVIKINE belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.